Bloxiverz FDA Approval History
FDA Approved: Yes (First approved May 31, 2013)
Brand name: Bloxiverz
Generic name: neostigmine methylsulfate
Dosage form: Injection
Company: Flamel Technologies
Treatment for: Reversal of Nondepolarizing Muscle Relaxants
Bloxiverz (neostigmine methylsulfate) is a cholinesterase inhibitor used for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery.
Development Timeline for Bloxiverz
|Jun 3, 2013||ApprovalFlamel Technologies Announces FDA Approval of Bloxiverz|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.